Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 26;30(4):3627-3636.
doi: 10.3390/curroncol30040276.

Patient-Initiated Follow-Up in Ovarian Cancer

Affiliations

Patient-Initiated Follow-Up in Ovarian Cancer

Hiu Mei Luk et al. Curr Oncol. .

Abstract

This study aimed to assess the feasibility of patient-initiated follow-up (PIFU) in combination with regular tumour marker monitoring as an alternative to conventional hospital follow-up for ovarian cancer survivors. Women who had recently completed treatment for ovarian cancer and had a raised pre-treatment tumour marker were recruited. Participants were allocated to PIFU (intervention group) or conventional hospital follow-up (control group) according to their own preference. Both groups had regular tumour marker monitoring. The change in fear of cancer recurrence (FCR) score as measured by the FCR inventory, and the supportive care need (SCN) scores as measured by the SCN survey at baseline and at 6 months between PIFU and hospital follow-up were compared. Out of 64 participants, 37 (58%) opted for hospital follow-up and 27 (42%) opted for PIFU. During the 6-month study period, there was no significant difference in the change of FCR between the two groups (p = 0.35). There was a significant decrease in the sexuality unmet needs score in the intervention group from baseline to 6-month FU (mean difference -8.7, 95% confidence interval -16.1 to -1.4, p = 0.02). PIFU with tumour marker monitoring is a feasible follow-up approach in ovarian cancer survivorship care. FCR and SCN were comparable between PIFU and conventional hospital follow-up.

Keywords: cancer survivorship; fear of cancer recurrence; ovarian cancer; patient-initiated follow-up; supportive care needs.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. The Global Cancer Observatory Cancer Today. [(accessed on 11 November 2022)]. Available online: https://gco.iarc.fr/today/data/factsheets/cancers/23-Cervix-uteri-fact-s....
    1. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Cervical Cancer. [(accessed on 11 November 2022)]. Available online: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1426.
    1. Lajer H., Jensen M.B., Kilsmark J., Albæk J., Svane D., Mirza M.R., Geertsen P.F., Reerman D., Hansen K., Milter M.C., et al. The value of gynecologic cancer follow-up: Evidence-based ignorance? Int. J. Gynecol. Cancer. 2010;20:1307–1320. doi: 10.1111/IGC.0b013e3181f3bee0. - DOI - PubMed
    1. Salani R., Backes F.J., Fung M.F.K., Holschneider C.H., Parker L.P., Bristow R.E., Goff B.A. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am. J. Obstet. Gynecol. 2011;204:466–478. doi: 10.1016/j.ajog.2011.03.008. - DOI - PubMed
    1. Jeppesen M.M., Mogensen O., Hansen D.G., Bergholdt S.H., Jensen P.T. How Do We Follow Up Patients With Endometrial Cancer? Curr. Oncol. Rep. 2019;21:57. doi: 10.1007/s11912-019-0805-3. - DOI - PubMed